{"id":103134,"date":"2025-07-29T21:55:11","date_gmt":"2025-07-29T21:55:11","guid":{"rendered":"https:\/\/www.europesays.com\/us\/103134\/"},"modified":"2025-07-29T21:55:11","modified_gmt":"2025-07-29T21:55:11","slug":"myriad-genetics-inc-to-host-second-quarter-2025-earnings-conference-call-on-august-5-2025","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/103134\/","title":{"rendered":"Myriad Genetics, Inc. to Host Second Quarter 2025 Earnings Conference Call on August 5, 2025"},"content":{"rendered":"<p>\n  SALT LAKE CITY, July  29, 2025  (GLOBE NEWSWIRE) &#8212;<br \/>\n  <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=FD16qmBWR4NAH_AQKCM24h3TZ9tehCDIeH-e51V1kUExO7i8aohnAUvDd9aEI9ZkETlubCK0obhJ8RN3TQpdmN6bPv5lTaPeIt0KLllbsYg=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"Myriad Genetics, Inc\"><br \/>\n   Myriad Genetics, Inc<br \/>\n  <\/a><br \/>\n  . (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, will hold its second quarter 2025 earnings conference call at 4:30pm ET on Tuesday, Aug. 5, 2025. The company\u2019s quarterly earnings will be released the same day after the market closes. During the call, Myriad management will provide a financial overview and business update of the company\u2019s performance for the second quarter 2025.\n <\/p>\n<p>\n  A live webcast of the conference call can be accessed on Myriad\u2019s Investor Relations website at<br \/>\n  <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=d4l7ohPGNyRfJ6BE2RqVwj8OosW7LEVAJlNQoRLVl2A7g14oMGIdDX_gHk_DiEwbGwUx-50-tV7KidWFxLjazoRb3-__AYoi4y_TvZB6voM=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"investor.myriad.com\"><br \/>\n   investor.myriad.com<br \/>\n  <\/a><br \/>\n  . To participate in the live conference call via telephone, please register<br \/>\n  <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=A8ilMavXRPSkIkaLlu8ZDNqxdVGESZQEezMR4nlXjK6vTTF5Luo_eG-bNXCyfvF9QbeEz14hkJN7JY_iqPNOmrAXqolDL_KS-At5A_MoTLIiBMAcLCaR-eXCZOj6Y58rVzUs7clHYtngZofz13ntBSzPIJ_CGnJJS2gF1xl0D0I=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"here\"><br \/>\n   here<br \/>\n  <\/a><br \/>\n  . Upon registering, a dial-in number and unique PIN will be provided to join the conference call. An archived webcast of the call will be available at<br \/>\n  <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=d4l7ohPGNyRfJ6BE2RqVwpzbe0s-JrlhfIjBP3Eu32Z-KZL5TR9VOc7SJohs81NaqoUSQBq6-4066WSoubFjpQrb_dqxqhjPRxo5gwmCxIs=\" rel=\"nofollow noopener\" target=\"_blank\" title=\"investor.myriad.com\"><br \/>\n   investor.myriad.com<br \/>\n  <\/a><br \/>\n  following the call.\n <\/p>\n<p>\n  <strong><br \/>\n   About Myriad Genetics<br \/>\n  <\/strong><br \/>\n  <br \/>Myriad Genetics is a leading molecular diagnostic testing and precision medicine company dedicated to advancing health and well-being for all. Myriad Genetics develops and offers molecular tests that help assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties where molecular insights can significantly improve patient care and lower healthcare costs. For more information, visit<br \/>\n  <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=-GQeM0l_nReNdwfeUBXqwmcDi6LElQLzLRYicLcs8XmKJGmce3nuFFVrJxhhVBRtFf83BXVN7ACWDqJRqN661g==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"www.myriad.com\"><br \/>\n   www.myriad.com<br \/>\n  <\/a><br \/>\n  .\n <\/p>\n<p>\n  <strong><br \/>\n   Investor Contact<br \/>\n  <\/strong><br \/>\n  <br \/>Matt Scalo<br \/>\n  <br \/>(801) 584-3532<br \/>\n  <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IEXN8w3S3w4GMsEJwUXjH7qe8HJOFIxu_qvgN7S_1bIpM4mzh8BcNTypLFrFGwX4TXxZv97ToRxDi6d_HIsg3A==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"\"><\/p>\n<p>    [email\u00a0protected]<\/p>\n<p>  <\/a>\n <\/p>\n<p>\n  <strong><br \/>\n   Media Contact<br \/>\n  <\/strong><br \/>\n  <br \/>Kate Schraml<br \/>\n  <br \/>(224) 875-4493<br \/>\n  <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=1rxWp7UnGiDC8ALedCwl0lvwOdvXN0PdZ89uYqL7ugPRp5PiCtNPjAhEeAMKDaAeHQQRu40ND_VEOkdZnLFLAQ==\" rel=\"nofollow noopener\" target=\"_blank\" title=\"PR@myriad.com\"><br \/>\n   [email\u00a0protected]<br \/>\n  <\/a>\n <\/p>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"SALT LAKE CITY, July 29, 2025 (GLOBE NEWSWIRE) &#8212; Myriad Genetics, Inc . (NASDAQ: MYGN), a leader in&hellip;\n","protected":false},"author":3,"featured_media":103135,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[815,159,67,132,68],"class_list":{"0":"post-103134","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-genetics","9":"tag-science","10":"tag-united-states","11":"tag-unitedstates","12":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/114938757390858220","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/103134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=103134"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/103134\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/103135"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=103134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=103134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=103134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}